Cu-Controlled Enantiodivergent Pd-Catalyzed Stille Cross-Coupling Reactions

07 February 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We report an enantiodivergent Pd-catalyzed cross-coupling reaction between unactivated enantioenriched alkylcarbastannatrane nucleophiles and aryl electrophiles in which the stereochemical course of the reaction is dictated by the inclusion or omission of a Cu(I) co-transmetalating agent. Use of a new electron-deficient biarylphosphine ligand (MaPhos) is required to promote the previously unreported stereoinvertive transmetalation pathway for unactivated secondary alkylstannanes. When a Cu(I) salt is included as a co-transmetalating agent, the stereochemical course of the reaction changes from stereoinvertive to stereoretentive. Thus, both enantiomers of the cross-coupling product can be accessed in high enantiopurity using a single achiral ligand. Mechanistic investigations suggest that net-stereoretentive alkyl transfer, in the presence of Cu(I), results from consecutive stereoretentive transmetalations from tin to copper and copper to palladium. In contrast, direct alkyl transmetalation from tin to palladium proceeds primarily via a stereoinvertive pathway that is facilitated by the presence of electron-deficient ligands.

Keywords

Palladium
Cross-coupling
Stereospecific
Stille

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Procedural details, compound characterization, NMR spectra, and HPLC data (PDF). CCDC 2379614 contains the crystallographic data for compound 8, and is available free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.